Andrew Simpson's most recent trade in Heart Test Laboratories Inc was a trade of 275,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on July 9, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Heart Test Laboratories Inc | Andrew Simpson | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 275,000 | 275,000 | - | - | Stock Option (Right to Buy) | |
| Heart Test Laboratories Inc | Andrew Simpson | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 68,750 | 68,750 | - | - | Restricted Stock Units | |
| Heart Test Laboratories Inc | Andrew Simpson | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2025 | 45,000 | 45,000 | - | - | Employee Stock Option (Right to Buy) | |
| Heart Test Laboratories Inc | Andrew Simpson | Director, See Remarks | Other type of transaction at price $ 0.00 per share. | 12 Aug 2024 | 17 | 7,629 | - | - | Common Stock, $0.001 par value | |
| Heart Test Laboratories Inc | Andrew Simpson | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Mar 2023 | 300,000 | 300,000 | - | - | Employee Stock Option (Right to Buy) |